GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Portfolio Pulse from Benzinga Insights
GoodRx Holdings (NASDAQ:GDRX) has received mixed ratings from analysts over the past three months, with a combination of bullish and bearish perspectives. The average 12-month price target has increased to $9.67. Analysts have adjusted their ratings and price targets based on recent developments, reflecting a range of opinions on the company's future performance.
August 16, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GoodRx Holdings has received a mix of bullish and bearish ratings from analysts over the past three months. The average 12-month price target has increased to $9.67, with a high estimate of $10.00 and a low estimate of $8.50. Analysts have adjusted their ratings and price targets based on recent developments, reflecting a range of opinions on the company's future performance.
The mixed ratings from analysts indicate uncertainty about GoodRx Holdings' future performance. The increase in the average 12-month price target suggests some optimism, but the range of ratings reflects differing opinions on the company's prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100